Evidence map›Paper›PMID 40715051›Full record

ArticleNature communications2025

Training a high-performance retinal foundation model with half-the-data and 400 times less compute.

Justin Engelmann, Miguel O Bernabeu

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. AI-driven multimodal retinal imaging for early detection and risk stratification of vascular and neurodegenerative diseases.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  2. Article
  3. Toward Reliable Diabetic Retinopathy Screening.Sensors (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Benchmarking Vision Encoders for Image Classification in Ophthalmology.Computational and structural biotechnology journal · 2026
    Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Justin EngelmannCentre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK. j.engelmann@ucl.ac.uk.
Miguel O BernabeuCentre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-6456-3756

Funding

Alan Turing Institute C-10180357Diabetes UK 20/0006221Fight for Sight (Fight for Sight, Inc.) 5137/5138Fondation Leducq 17 CVD 03RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/S02431X/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/X025705/1RCUK | Medical Research Council (MRC) MR/Y011651/1
6 · The paper itself

Abstract

Medical artificial intelligence is limited by available training datasets. Foundation models like RETFound from Moorfields Eye Hospital (MEH) can be adapted with small downstream datasets and thus alleviate this issue. RETFound-MEH used 900,000 training images. Recently, "data-efficient" DERETFound achieved comparable performance with 150,000 images. Both require very substantial compute resources for training and use. We propose RETFound-Green trained on only 75,000 publicly available images with 400 times less compute using a novel Token Reconstruction objective. RETFound-MEH and DERETFound training costs are estimated at $10,000 and $14,000, respectively. RETFound-Green cost less than $100, with equally reduced environmental impact. RETFound-Green can be downloaded 14 times faster, computes vector embeddings 2.7 times faster which then require 2.6 times less storage space. On a variety of downstream tasks from geographically diverse datasets, RETFound-Green achieves more than twice as many statistically significant wins than the next best model.

Indexed as

Artificial IntelligenceImage Processing, Computer-AssistedRetinaAlgorithmsHumans

Identifiers

PMID40715051
PMCPMC12297332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.